The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease.
about
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityPathogen induced changes in the protein profile of human tears from Fusarium keratitis patients.Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants.Alpha 1-antitrypsin and serum albumin in tear fluids in acute adenovirus conjunctivitis.The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization.The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes.Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shuntLymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiencyReference ranges for serum alpha 1 antitrypsin.Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer.alpha1-Antitrypsin deficiency and hepatocellular cancer.Furazolidone-induced cardiomyopathy in turkeys. Association with a relative alpha1-antitrypsin deficiencyPathologic aspects of cirrhosis. A review.Alpha 1-antitrypsin screening of 18-year-old men.Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency.Methods to determine intestinal permeability and bacterial translocation during liver disease.Alpha-1-antitrypsin deficiency: a biological enigma.Alpha-1-antitrypsin bodies in the liver.Hepatitis, cardiomyopathy and hemodynamics in furazolidone-induced round heart disease of turkeys.Alpha-1-antitrypsin globules in the liver and PiM phenotype.Disease of the liver associated with alpha1-antitrypsin deficiency.Limited proteolysis by macrophage elastase inactivates human alpha 1-proteinase inhibitor.Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
P2860
Q26773267-8F3C4AFD-E0BA-43B6-8E3C-EBB52D7D0BC4Q28283069-59110F29-4057-4137-8F6D-C091C7391F8CQ30421984-3A38FF45-DFD9-4A63-B1E3-27824CCB46A8Q33646400-79D189BB-8975-4BAE-A50D-7C087352B37EQ33846319-3E41BE81-20DB-4DFB-9AE4-C4EA031137FBQ33929609-0DDD685B-ECF6-42CA-A696-665AE9BB1E6BQ34310155-81E845BC-379B-4306-89F8-1241B080ADE1Q34526108-2884B803-83AB-4626-A15D-B6730A29D553Q35601766-1278A4E6-E239-48EB-8EB2-FBE18C2FBA4BQ35991389-15F85AB7-1789-413E-871D-487281073BDBQ36042038-64FF67AC-562C-467C-A487-4839C0F6E502Q36058752-74E0BBED-1AD7-4B3C-B55C-C4925207F3D4Q36076957-54FAA310-34B7-48F8-8397-719FF300E0F2Q36456890-6CC04C54-1140-4858-A33F-86EAED3FB30BQ37421349-457BC616-8032-4674-83ED-86A2CA6EC7B3Q38321290-49EEFFD5-B0A6-41F6-9CA3-79A146AF18D9Q39762361-0F586209-2E4E-431E-B122-428C866A187AQ40058873-6FAF6E41-8191-4650-8146-97AEE37DCA9FQ40296673-AC892043-A0BC-4F72-90BD-05FCA77D73D5Q40647724-4BECF1B3-3D43-4731-9622-D9A206DBD743Q40651171-A7BC46DF-5DD0-456A-926D-107E2DF05181Q42935360-2C232835-40C7-45BB-B445-7C08956328EBQ45873139-0B8D956B-8555-45CA-A3CD-5A52911B9561
P2860
The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
The current status of alpha-1- ...... , in gastrointestinal disease.
@en
type
label
The current status of alpha-1- ...... , in gastrointestinal disease.
@en
prefLabel
The current status of alpha-1- ...... , in gastrointestinal disease.
@en
P1433
P1476
The current status of alpha-1- ...... , in gastrointestinal disease.
@en
P2093
P304
P407
P577
1976-04-01T00:00:00Z